TMO
Thermo Fisher Scientific Inc
NYSE: TMO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$478.96
+2.72% today
Updated 2026-04-30
Market cap
$173.27B
P/E ratio
25.65
P/S ratio
3.83x
EPS (TTM)
$18.18
Dividend yield
0.37%
52W range
$384 – $643
Volume
2.0M
Thermo Fisher Scientific Inc (TMO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $405.65M | $1.48B | $1.42B | $1.66B | $1.50B | $1.69B | $2.04B | $2.01B | $2.62B | $2.82B | $3.16B | $4.00B | $4.54B | $4.97B | $8.29B | $9.54B | $9.15B | $8.41B | $8.67B | $7.82B |
| Capital expenditures | $76.80M | $175.50M | $264.40M | $207.50M | $265.50M | $266.50M | $315.10M | $282.40M | $427.60M | $422.90M | $444.40M | $508.00M | $758.00M | $926.00M | $1.47B | $2.52B | $2.24B | $1.48B | $1.40B | $1.52B |
| Depreciation | $240.77M | $756.80M | $792.70M | $787.30M | $770.00M | $863.50M | $983.70M | $999.90M | $1.68B | $1.69B | $1.76B | $2.03B | $2.27B | $2.28B | $2.33B | $2.59B | $3.38B | $3.41B | $3.11B | $2.78B |
| Stock-based comp | $1.76M | $51.10M | $57.10M | $68.10M | $83.10M | $80.20M | $78.20M | $90.90M | $117.10M | $125.00M | $133.50M | $159.00M | $181.00M | $181.00M | $196.00M | $230.00M | $307.00M | $278.00M | $301.00M | $310.00M |
| Free cash flow | $328.86M | $1.31B | $1.16B | $1.45B | $1.23B | $1.42B | $1.72B | $1.73B | $2.19B | $2.39B | $2.71B | $3.50B | $3.79B | $4.05B | $6.82B | $7.02B | $6.91B | $6.93B | $7.27B | $6.29B |
| Investing cash flow | $283.45M | $-586.00M | $-450.00M | $-829.50M | $-858.90M | $-5.14B | $-1.33B | $-263.30M | $-11.78B | $-1.09B | $-5.53B | $-7.73B | $-1.25B | $-1.49B | $-1.51B | $-21.93B | $-2.16B | $-5.14B | $-5.84B | $-4.05B |
| Financing cash flow | $-260.10M | $-928.70M | $-228.40M | $-557.50M | $-1.30B | $3.55B | $-917.70M | $3.31B | $4.80B | $-2.62B | $2.86B | $3.85B | $-2.24B | $-3.12B | $959.00M | $6.58B | $-2.81B | $-3.62B | $-6.79B | $1.80B |
| Dividends paid | — | — | — | $748.20M | $741.40M | $5.16B | $142.20M | $216.20M | $234.80M | $240.60M | $238.40M | $237.00M | $266.00M | $297.00M | $337.00M | $395.00M | $455.00M | $523.00M | $583.00M | $636.00M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $283.60M | $-647.00M | $99.20M | $-165.30M | $5.02B | $-4.48B | $-891.40M | $334.10M | $130.00M | $1.05B | $368.00M | $7.74B | $-6.04B | $4.18B | — | — | — |